BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30848097)

  • 1. Impact of molecular testing in clinical practice in gynecologic cancers.
    Huang M; Hunter T; Slomovitz B; Schlumbrecht M
    Cancer Med; 2019 May; 8(5):2013-2019. PubMed ID: 30848097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
    Somasegar S; Hoppenot C; Kuchta K; Sereika A; Khandekar J; Rodriguez G; Moore E; Hurteau J; Vogel TJ
    Gynecol Oncol; 2021 Nov; 163(2):220-228. PubMed ID: 34511240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers.
    Watson CH; Broadwater G; Wong J; Spinosa D; de Oca MKM; Datto M; Green M; Hubbard C; McKinney M; McCall SJ; Havrilesky LJ; Strickler JH; Berchuck A; Strickland KC; Previs RA
    Target Oncol; 2021 Jan; 16(1):109-118. PubMed ID: 33400095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers.
    Jones TE; Zou J; Tseng GC; Roy S; Bhargava R
    Am J Clin Pathol; 2021 Aug; 156(3):455-460. PubMed ID: 33728425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
    Rodriguez-Freixinos V; Lheureux S; Mandilaras V; Clarke B; Dhani NC; Mackay H; Butler MO; Wang L; Siu LL; Kamel-Reid S; Stockley T; Bedard PL; Oza AM
    Gynecol Oncol; 2019 May; 153(2):304-311. PubMed ID: 30792002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers.
    Rodriguez-Rodriguez L; Hirshfield KM; Rojas V; DiPaola RS; Gibbon D; Hellmann M; Isani S; Leiser A; Riedlinger GM; Wagreich A; Ali SM; Elvin JA; Miller VA; Ganesan S
    Gynecol Oncol; 2016 Apr; 141(1):2-9. PubMed ID: 27016222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
    Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
    PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing: Role in Gynecologic Cancers.
    Evans T; Matulonis U
    J Natl Compr Canc Netw; 2016 Sep; 14(9):1165-73. PubMed ID: 27587626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.
    Varnier R; Le Saux O; Chabaud S; Garin G; Sohier E; Wang Q; Paindavoine S; Pérol D; Baudet C; Attignon V; Pissaloux D; Heudel P; You B; Leyronnas C; Collard O; Trédan O; Bonnin N; Long J; Jacquin JP; Cassier PA; Derbel O; Freyer G; Viari A; Blay JY; Ray-Coquard I
    Eur J Cancer; 2019 Sep; 118():156-165. PubMed ID: 31351267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.
    Nie Q; Omerza G; Chandok H; Prego M; Hsiao MC; Meyers B; Hesse A; Uvalic J; Soucy M; Bergeron D; Peracchio M; Burns S; Kelly K; Rowe S; Rueter J; Reddi HV
    Cancer Genet; 2020 Apr; 242():25-34. PubMed ID: 31992506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
    Taghizadeh H; Mader RM; Müllauer L; Aust S; Polterauer S; Kölbl H; Seebacher V; Grimm C; Reinthaller A; Prager GW
    Oncologist; 2020 Jul; 25(7):e1060-e1069. PubMed ID: 32369643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
    Sultova E; Westphalen CB; Jung A; Kumbrink J; Kirchner T; Mayr D; Rudelius M; Ormanns S; Heinemann V; Metzeler KH; Greif PA; Burges A; Trillsch F; Mahner S; Harbeck N; Wuerstlein R
    Arch Gynecol Obstet; 2021 May; 303(5):1331-1345. PubMed ID: 33277683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of a formalized precision medicine program in gynecologic oncology.
    Gunderson CC; Rowland MR; Wright DL; Andrade KL; Mannel RS; McMeekin DS; Moore KN
    Gynecol Oncol; 2016 Apr; 141(1):24-8. PubMed ID: 27016225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tragic results of suboptimal gynecologic cancer operations.
    Kuyumcuoğlu U; Kale A
    Eur J Gynaecol Oncol; 2008; 29(6):620-7. PubMed ID: 19115691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers.
    Wang M; Fan W; Ye M; Tian C; Zhao L; Wang J; Han W; Yang W; Gu C; Li M; Zhang Z; Wang Y; Zhang H; Meng Y
    Sci Rep; 2018 Jun; 8(1):8990. PubMed ID: 29895933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of New Cancer Treatment by Identifying and Focusing the Genetic Mutations or Altered Expression in Gynecologic Cancers.
    Tang YH; Lin CY; Lai CH
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
    Kraus FBT; Sultova E; Heinrich K; Jung A; Westphalen CB; Tauber CV; Kumbrink J; Rudelius M; Klauschen F; Greif PA; König A; Chelariu-Raicu A; Czogalla B; Burges A; Mahner S; Wuerstlein R; Trillsch F
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.
    Penson RT; Sales E; Sullivan L; Borger DR; Krasner CN; Goodman AK; del Carmen MG; Growdon WB; Schorge JO; Boruta DM; Castro CM; Dizon DS; Birrer MJ
    Gynecol Oncol; 2016 Apr; 141(1):108-12. PubMed ID: 27016236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT).
    Arians N; Foerster R; Rom J; Uhl M; Roeder F; Debus J; Lindel K
    Radiat Oncol; 2016 Mar; 11():44. PubMed ID: 26988089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic insights in gynecologic cancer.
    Roddy E; Chapman J
    Curr Probl Cancer; 2017; 41(1):8-36. PubMed ID: 28088330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.